Pyridoxine Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Pyridoxine Hydrochloride
US Patents

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Pyridoxine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 8 USDMF, 6 CEP/COS, 5 JDMF, 1 KDMF, 8 NDC API, 20 Listed Suppliers, $ API Reference Price

31 API Suppliers
8 USDMF
6 CEP/COS
5 JDMF
1 KDMF
8 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

319 FDF Dossiers, 35 FDA Orange Book, 41 Europe, 7 Canada, 113 South Africa, 123 Listed Dossiers

319 FDF Dossiers
35 FDA Orange Book
41 Europe
7 Canada
113 South Africa
123 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML
INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL
INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

4 Evonik, 11 Rochem International Inc, 22 SPI Pharma, 2 Seqens, 19 DKSH, 2 Pharm-RX Chemical, 11 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 2 Kewpie Corporation, 17 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 4 ACG Worldwide, 15 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 39 BASF, 1 Bioplus Life Sciences, 2 Clariant, 17 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 3 Finar, 15 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 34 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 23 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 13 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 39 Roquette, 18 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

114 Fillers, Diluents & Binders, 76 Coating Systems & Additives, 52 Solubilizers, 50 Thickeners and Stabilizers, 50 Direct Compression, 47 Controlled & Modified Release, 46 Taste Masking, 42 Parenteral, 38 Topical, 34 Disintegrants & Superdisintegrants, 32 Granulation, 31 Film Formers & Plasticizers, 25 Lubricants & Glidants, 22 Chewable & Orodispersible Aids, 22 Co-Processed Excipients, 22 Emulsifying Agents, 14 Rheology Modifiers, 11 API Stability Enhancers, 10 Surfactant & Foaming Agents, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

114 Fillers, Diluents & Binders
76 Coating Systems & Additives
52 Solubilizers
50 Thickeners and Stabilizers
50 Direct Compression
47 Controlled & Modified Release
46 Taste Masking
42 Parenteral
38 Topical
34 Disintegrants & Superdisintegrants
32 Granulation
31 Film Formers & Plasticizers
25 Lubricants & Glidants
22 Chewable & Orodispersible Aids
22 Co-Processed Excipients
22 Emulsifying Agents
14 Rheology Modifiers
11 API Stability Enhancers
10 Surfactant & Foaming Agents
9 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 32 NEWS #PharmaBuzz

5 DATA COMPILATION #PharmaFlow
32 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

27 Finished Drug Prices

27 Finished Drug Prices

MARKET PLACE

77 APIs, 8 FDF Dossiers, 1 EXCIPIENTS

77 APIs
8 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 2 JP, 16 Others

2 EDQM
1 USP
2 JP
16 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ API Ref.Price (USD/KG) : 23 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4DUCHESNAY

filter Patent Number Reset all filters

4 All

01 19089489

02 19375404

03 19526703

04 19937132

filter API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 4Y

filter Expiration Date Reset all filters

4 All

01 42033-02-18

Product Main Page

01

DUCHESNAY

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

DUCHESNAY

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-02-18

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

US Patent Number : 9937132

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209661

Patent Use Code : U-1382

Delist Requested :

Patent Use Description : TREATMENT OF NAUSEA AN...

Patent Expiration Date : 2033-02-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

DUCHESNAY

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

DUCHESNAY

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-02-18

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

US Patent Number : 9375404

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209661

Patent Use Code : U-1382

Delist Requested :

Patent Use Description : TREATMENT OF NAUSEA AN...

Patent Expiration Date : 2033-02-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

DUCHESNAY

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

DUCHESNAY

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-02-18

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

US Patent Number : 9526703

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209661

Patent Use Code : U-1382

Delist Requested :

Patent Use Description : TREATMENT OF NAUSEA AN...

Patent Expiration Date : 2033-02-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

DUCHESNAY

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Antibody Engineering

Not Confirmed

DUCHESNAY

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-02-18

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

US Patent Number : 9089489

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209661

Patent Use Code : U-1382

Delist Requested :

Patent Use Description : TREATMENT OF NAUSEA AN...

Patent Expiration Date : 2033-02-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?